Global IV Solution Bags Market Size, Competition and Demand Analysis Report #InsightsIV solution bags, also known as IV bags or IV fluid bags, are medical devices used to administer fluids, medications, and nutrients directly into a patient's bloodstream through an intravenous (IV) catheter. They are commonly used in hospitals, clinics, and other medical facilities. IV bags are typically made of flexible plastic and come in different sizes, ranging from 50 mL to 1,000 mL or more. The most common sizes are 250 mL and 500 mL. The bags are usually filled with sterile saline solution, a salt and water solution that closely mimics human blood's electrolyte balance. Other IV solutions can also be used, such as dextrose solution, which contains glucose, or lactated Ringer's solution, which contains various electrolytes. Report Forecast The global IV Solution Bags market was valued at US$ xx million in 2022 and is anticipated to reach US$ xx million by 2029, witnessing a...Read more | USD 2,900.00 |
Global Atelocollagen Market Research Report 2022As the global economy recovers in 2021 and the supply of the industrial chain improves, the Atelocollagen market will undergo major changes. According to the latest research, the market size of the Atelocollagen industry in 2021 will increase by USD million compared to 2020, with a growth rate of %. The global Atelocollagen industry report provides top-notch qualitative and quantitative information including: Market size (2017-2021 value and 2022 forecast). The report also contains descriptions of key players, including key financial indicators and market competitive pressure analysis. The report also assesses key opportunities in the market and outlines the factors that are and will drive the growth of the industry. Taking into account previous growth patterns, growth drivers, and current and future trends, we also forecast the overall growth of the global Atelocollagen market during the next few years. The global Atelocollagen market size will reach USD...Read more | USD 3,360.00 |
Global Ophthalmic Drug Delivery System Market 2021-2031 by Product , Dosage Form , Disease , Setting , and Region: Trend Forecast and Growth OpportunityGlobal ophthalmic drug delivery system market will reach $ 30,013.7 million by 2031, growing by 6.9% annually over 2021-2031, driven by the growing prevalence of ophthalmic diseases, the emerging novel ocular drug delivery systems, rise in number of ophthalmic procedures that require attentive post procedural care, and the increasing demand to deliver controlled dosage forms for pediatric and geriatric population. Highlighted with 80 tables and 89 figures, this 196-page report “Global Ophthalmic Drug Delivery System Market 2021-2031 by Product (Syringes, Eyedroppers, Dispensers, Sprayers, Contact Lenses, Inserts, Implants, Plugs), Dosage Form (Solutions, Gels, Ointments, Suspensions, Emulsions, Liposomes & Nanoparticles), Disease (Glaucoma, Diabetic Retinopathy, Cataract, Dry Eye Syndrome, Macular Degeneration, Diabetic Macular Edema, Refractive Issues), Setting (Hospitals, Clinics, Homecare Settings, ASCs, Others), and Region: Trend Forecast and Growth Opportunity” is...Read more | USD 3,580.00 |
North America Ophthalmic Drug Delivery System Market 2021-2031 by Product , Dosage Form , Disease , Setting , and Country: Trend Forecast and Growth OpportunityNorth America ophthalmic drug delivery system market is projected to grow by 6.1% annually in the forecast period and reach $12,809.8 million by 2031, driven by the growing prevalence of ophthalmic diseases, the emerging novel ocular drug delivery systems, rise in number of ophthalmic procedures that require attentive post procedural care, and the increasing demand to deliver controlled dosage forms for pediatric and geriatric population. Highlighted with 20 tables and 53 figures, this 116-page report “North America Ophthalmic Drug Delivery System Market 2021-2031 by Product (Syringes, Eyedroppers, Dispensers, Sprayers, Contact Lenses, Inserts, Implants, Plugs), Dosage Form (Solutions, Gels, Ointments, Suspensions, Emulsions, Liposomes & Nanoparticles), Disease (Glaucoma, Diabetic Retinopathy, Cataract, Dry Eye Syndrome, Macular Degeneration, Diabetic Macular Edema, Refractive Issues), Setting (Hospitals, Clinics, Homecare Settings, ASCs, Others), and Country: Trend...Read more | USD 2,980.00 |
Europe Ophthalmic Drug Delivery System Market 2021-2031 by Product , Dosage Form , Disease , Setting , and Country: Trend Forecast and Growth OpportunityEurope ophthalmic drug delivery system market was valued at $3,856.3 million in 2021 and will grow by 6.4% annually over 2021-2031, driven by the growing prevalence of ophthalmic diseases, the emerging novel ocular drug delivery systems, rise in number of ophthalmic procedures that require attentive post procedural care, and the increasing demand to deliver controlled dosage forms for pediatric and geriatric population. Highlighted with 30 tables and 57 figures, this 127-page report “Europe Ophthalmic Drug Delivery System Market 2021-2031 by Product (Syringes, Eyedroppers, Dispensers, Sprayers, Contact Lenses, Inserts, Implants, Plugs), Dosage Form (Solutions, Gels, Ointments, Suspensions, Emulsions, Liposomes & Nanoparticles), Disease (Glaucoma, Diabetic Retinopathy, Cataract, Dry Eye Syndrome, Macular Degeneration, Diabetic Macular Edema, Refractive Issues), Setting (Hospitals, Clinics, Homecare Settings, ASCs, Others), and Country: Trend Forecast and Growth Opportunity...Read more | USD 2,980.00 |